Company Profiles

driven by the PitchBook Platform

AtoxBio

Description

Developer of therapeutics for diseases mediated by inflammatory response. The company focuses on developing novel modulators of immune response that target multiple and interrelated pathways of both the adaptive and innate immune response that play critical roles in infectious and inflammatory diseases.

2003

Founded

PRIVATE

Status

11-50

Employees

Series E

Latest Deal Type

$23M

Latest Deal Amount

$28.4M

Total Amount Raised

Description

Developer of therapeutics for diseases mediated by inflammatory response. The company focuses on developing novel modulators of immune response that target multiple and interrelated pathways of both the adaptive and innate immune response that play critical roles in infectious and inflammatory diseases.

Website:

www.atoxbio.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Other Pharmaceuticals and Biotechnology
Drug Discovery

Primary Office

8 Pinhas Sapir Street Weizmann Science Park Ness Ziona 7403631Israel +972 (0)8 648 4111
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore AtoxBio's full profile, request a free trial.

    AtoxBio Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    AtoxBio Investors (7)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Defense Advanced Research Projects AgencyGovernment000 0000000 0000
    Esperante VenturesVenture CapitalMinority000 0000000 0000
    Integra HoldingsVenture CapitalMinority000 0000000 0000
    Lundbeckfond VenturesVenture CapitalMinority000 0000000 0000
    National Institute Of Allergy and Infectious Diseases Extramural ActivitesGovernment000 0000000 0000
    Defense Advanced Research Projects Agency Government
    Esperante Ventures Venture Capital
    Integra Holdings Venture Capital
    Lundbeckfond Ventures Venture Capital
    National Institute Of Allergy and Infectious Diseases Extramural Activites Government

    AtoxBio Executive Team (8)

    NameTitleBoard
    Seat
    Contact
    Info
    Dan TelemanCo-Founder & Chief Executive Officer
    Esti HayunChief Financial Officer
    Gila AradCo-Founder, Scientific Consulter and Director of Research and Development
    Raymond Kaempfer Ph.DScientific Founder
    Anat Shirvan Ph.DExecutive Vice President, Research & Development
    Dan Teleman Co-Founder & Chief Executive Officer
    Esti Hayun Chief Financial Officer
    Gila Arad Co-Founder, Scientific Consulter and Director of Research and Development
    Raymond Kaempfer Ph.D Scientific Founder
    Anat Shirvan Ph.D Executive Vice President, Research & Development

    AtoxBio Board Members (9)

    NameRepresentingRoleSinceContact
    Info
    Bob TrachtenbergSelfBoard Member000 0000
    Casper BreumLundbeckfond VenturesSenior Partner000 0000
    Dane RossAtoxBioBoard Member000 0000
    Daniel BurgessSelfChairman000 0000
    Dean SlagelEsperante VenturesManaging Director000 0000
    Bob Trachtenberg Board Member Self
    Casper Breum Senior Partner Lundbeckfond Ventures
    Dane Ross Board Member AtoxBio
    Daniel Burgess Chairman Self
    Dean Slagel Managing Director Esperante Ventures
    Request full access to PitchBook